SEARCH

SEARCH BY CITATION

References

  • Behre HM, Kliesch S, Pu¨ Hse G, Reissmann T, Nieschlag E, 1997: High loading and low maintenance doses of a gonadotrophin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle- stimulating hormone, and testosterone in normal men. J Clin Endocrinol Metab 82, 14031408.
  • Broqua P, Riviere PJ, Conn PM, Rivier JE, Aubert ML, Junien JL, 2002: Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix. J Pharmacol Exp Ther 301, 95102.
  • García Romero G, Valiente C, Aquilano D, Corrada Y, Gobello C, 2009: Endocrine effects of the GnRH antagonist, acyline, in domestic dogs. Theriogenology 71, 12341237.
  • García Romero G, Fernández PE, Gimeno E, Barbeito C, Gobello C, 2012a: Effects of the GnRH antagonist acyline on the testis of the domestic cat (Felis catus). Vet J 193, 279282.
  • García Romero G, Mattioli G, Rosa D, Diaz JD, Abeyá M, Gobello C, 2012b: A single administration of the GnRH antagonist acyline inhibits basal and GnRH-stimulated serum testosterone concentrations in male dogs. Reprod Domest Anim 47, e32e35.
  • Garrett C, Liu DY, McLachlan RI, Baker HW, 2005: Time course of changes in sperm morphometry and semen variables during testosterone-induced suppression of human spermatogenesis. Hum Reprod 20, 30913100.
  • Gobello C, 2007: New GnRH analogs in canine reproduction. Anim Reprod Sci 100, 113.
  • Gonzalez Bulnes A, Lopez Sebastian A, Garcia Garcia RM, Veiga Lopez A, Souza CJH, McNeilly AS, 2005: Restoration of endocrine and ovarian function after stopping GnRH antagonist treatment in goats. Theriogenology 63, 8391.
  • Heber D, Dobson R, Swerdloff RS, Channabasavaiah K, Stewart JM, 1982: Pituitary receptor site blockade by a gonadotropin-releasing antagonist in vivo: mechanism of action. Science 216, 420421.
  • Herbst KL, Coviello AD, Page ST, Amory JK, Anawalt BD, Bremner WJ, 2004: Acyline, a gonadotropin releasing-hormone antagonist suppresses gonadotropins and testosterone for 15 days after a single dose. J Clin Endocrinol Metab 89, 59595965.
  • Hull ME, Kenigsberg DJ, 1987: Gonadotropin releasing hormone: function and clinical use. Lab Manag 25, 5158.
  • Jiang GC, Stalewski J, Galyean R, Dykert J, Schteingart C, Broqua P, Aebi A, Aubert ML, Semple G, Robson P, Akinsanya K, Haigh R, Riviere P, Trojnar J, Junien JL, Rivier JE, 2001: GnRH antagonists: a new generation of long acting analogues incorporating para-ureido-phenylalanines at position 5 and 6. J Med Chem 44, 453467.
  • Misro MM, Ganguly A, Das RP, 1992: Adverse effects of chronic GnRH antagonist administration on seminiferous epithelium in adult rats. Arch Androl 29, 6978.
  • Pelican KM, Brown JL, Wildt DE, Ottinger MA, Howard JG, 2005: Short term suppression of follicular recruitment and spontaneous ovulation in the cat using levonorgestrel versus a GnRH antagonist. Gen Comp Endocrinol 144, 110121.
  • Pelican KM, Wildt DE, Ottinger MA, Howard J, 2008: Priming with progestin, but not GnRH antagonist, induces a consistent endocrine response to exogenous gonadotropins in induced and spontaneously ovulating cats. Domest Anim Endocrinol 34, 160175.
  • Risso A, Valiente C, Corrada Y, Romero GG, Blanco PG, de la Sota PE, Diaz JD, Gobello C, 2010: The GnRH antagonist acyline prevented ovulation, but did not affect ovarian follicular development or gestational corpora lutea in the domestic cat. Theriogenology 73, 984987.
  • Schwahn M, Nagaraja NV, Derendorf H, 2000: Population pharmacokinetic/pharmacodynamic modeling of cetrorelix, a novel LH-RH antagonist, and testosterone in rats and dogs. Pharm Res 17, 328335.
  • Sharma OP, Weinbauer GF, Behre HM, Nieschlag E, 1992: The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primate. Urol Res 20, 317321.
  • Valiente C, Corrada Y, de la Sota PE, Galassi Gerez P, Gobello C, 2007: Effect of the GnRH antagonist, acyline, on canine testicular characteristics. Theriogenology 68, 687692.
  • Valiente C, Corrada Y, de la Sota PE, Blanco PG, Arias D, Gobello C, 2009a: Comparison of two doses of the GnRH antagonist, acyline, for pregnancy termination in bitches. Reprod Domest Anim (Suppl) 44, 156159.
  • Valiente C, Diaz JD, Rosa DE, Mattioli G, García Romero G, Gobello C, 2009b: Effect of a GnRH antagonist on GnRH agonist-implanted anestrous bitches. Theriogenology 72, 926929.
  • Valiente C, Romero GG, Corrada Y, de la Sota PE, Hermo G, Gobello C, 2009c: Interruption of the canine estrous cycle with a low and a high dose of the GnRH antagonist, acyline. Theriogenology 71, 408411.
  • Vickery BH, 1985: Comparisons the potential utility of LHRH agonists and antagonists for fertility control. J Steroid Biochem 23, 779791.
  • Vickery BH, McRae GI, Goodpasture JC, Sanders LM, 1989: Use of potent LHRH analogues for chronic contraception and pregnancy termination. J Reprod Fertil 39, 175187.
  • Wright PJ, Verstegen JP, Onclin K, Jochle WJ, Armour AF, Martin GB, Trigg TE, 2001: The suppression by progestin of oestrus responses of the bitch to the GnRH analogue deslorelin. J Reprod Fertil 57, 263268.